<VariationArchive RecordType="classified" VariationID="135674" VariationName="NM_005660.3(SLC35A2):c.433_434del (p.Tyr145fs)" VariationType="Deletion" Accession="VCV000135674" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-29" DateCreated="2020-10-23" MostRecentSubmission="2020-10-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="139386" VariationID="135674">
      <GeneList>
        <Gene Symbol="SLC35A2" FullName="solute carrier family 35 member A2" GeneID="7355" HGNC_ID="HGNC:11022" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48903183" stop="48911958" display_start="48903183" display_stop="48911958" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NW_025791820.1" start="62018" stop="70793" display_start="62018" display_stop="70793" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48760458" stop="48769234" display_start="48760458" display_stop="48769234" Strand="-" />
          </Location>
          <OMIM>314375</OMIM>
          <Haploinsufficiency last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC35A2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC35A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005660.3(SLC35A2):c.433_434del (p.Tyr145fs)</Name>
      <CanonicalSPDI>NC_000023.11:48905474:TAT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48905475" stop="48905476" display_start="48905475" display_stop="48905476" variantLength="2" positionVCF="48905474" referenceAlleleVCF="GTA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48762752" stop="48762753" display_start="48762752" display_stop="48762753" variantLength="2" positionVCF="48762751" referenceAlleleVCF="GTA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Y173fs</ProteinChange>
      <ProteinChange>Y84fs</ProteinChange>
      <ProteinChange>Y145fs</ProteinChange>
      <ProteinChange>Y158fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005660.3" sequenceAccession="NM_005660" sequenceVersion="3" change="c.433_434del" MANESelect="true">
            <Expression>NM_005660.3:c.433_434del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005651.1" sequenceAccession="NP_005651" sequenceVersion="1" change="p.Tyr145fs">
            <Expression>NP_005651.1:p.Tyr145fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282647.2" sequenceAccession="NM_001282647" sequenceVersion="2" change="c.427-584_427-583del">
            <Expression>NM_001282647.2:c.427-584_427-583del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282648.2" sequenceAccession="NM_001282648" sequenceVersion="2" change="c.355-584_355-583del">
            <Expression>NM_001282648.2:c.355-584_355-583del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001032289.3" sequenceAccession="NM_001032289" sequenceVersion="3" change="c.427-584_427-583del">
            <Expression>NM_001032289.3:c.427-584_427-583del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48762753_48762754del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48762753_48762754del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.48905476_48905477del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.48905476_48905477del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_034300.1" sequenceAccession="NG_034300" sequenceVersion="1" change="g.11483_11484del">
            <Expression>NG_034300.1:g.11483_11484del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042498.3" sequenceAccession="NM_001042498" sequenceVersion="3" change="c.433_434del">
            <Expression>NM_001042498.3:c.433_434del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035963.1" sequenceAccession="NP_001035963" sequenceVersion="1" change="p.Tyr145fs">
            <Expression>NP_001035963.1:p.Tyr145fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282649.2" sequenceAccession="NM_001282649" sequenceVersion="2" change="c.250_251del">
            <Expression>NM_001282649.2:c.250_251del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269578.1" sequenceAccession="NP_001269578" sequenceVersion="1" change="p.Tyr84fs">
            <Expression>NP_001269578.1:p.Tyr84fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282650.2" sequenceAccession="NM_001282650" sequenceVersion="2" change="c.472_473del">
            <Expression>NM_001282650.2:c.472_473del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269579.1" sequenceAccession="NP_001269579" sequenceVersion="1" change="p.Tyr158fs">
            <Expression>NP_001269579.1:p.Tyr158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282651.2" sequenceAccession="NM_001282651" sequenceVersion="2" change="c.517_518del">
            <Expression>NM_001282651.2:c.517_518del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269580.1" sequenceAccession="NP_001269580" sequenceVersion="1" change="p.Tyr173fs">
            <Expression>NP_001269580.1:p.Tyr173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="314375.0004" DB="OMIM" />
        <XRef Type="rs" ID="587777434" DB="dbSNP" />
        <XRef ID="CA163125" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005660.3(SLC35A2):c.433_434del (p.Tyr145fs) AND SLC35A2-congenital disorder of glycosylation" Accession="RCV000122744" Version="4">
        <ClassifiedConditionList TraitSetID="9706">
          <ClassifiedCondition DB="MedGen" ID="C3806688">SLC35A2-congenital disorder of glycosylation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-10-23" MostRecentSubmission="2020-10-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24115232</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9706" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17835" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm</ElementValue>
                <XRef Type="MIM" ID="300896" DB="OMIM" />
                <XRef Type="Allelic variant" ID="314375.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CDG IIm</ElementValue>
                <XRef Type="MIM" ID="300896" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm, SOMATIC MOSAIC</ElementValue>
                <XRef Type="Allelic variant" ID="314375.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="314375.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 22</ElementValue>
                <XRef Type="Allelic variant" ID="314375.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="314375.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="314375.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">SLC35A2-congenital disorder of glycosylation</ElementValue>
                <XRef ID="MONDO:0010478" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC35A2-CDG</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 22</ElementValue>
                <XRef Type="MIM" ID="300896" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EIEE22</ElementValue>
                <XRef Type="MIM" ID="300896" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CDG2M</ElementValue>
                <XRef Type="MIM" ID="300896" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CDGIIm</ElementValue>
                <XRef Type="MIM" ID="300896" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12403" />
                <XRef ID="12403" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="356961" DB="Orphanet" />
              <XRef ID="C3806688" DB="MedGen" />
              <XRef ID="MONDO:0010478" DB="MONDO" />
              <XRef Type="MIM" ID="300896" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="286893" SubmissionDate="2020-10-13" DateLastUpdated="2020-10-23" DateCreated="2014-06-16">
        <ClinVarSubmissionID localKey="314375.0004_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 22" title="SLC35A2, 2-BP DEL, 433TA_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 22" />
        <ClinVarAccession Accession="SCV000166001" DateUpdated="2020-10-23" DateCreated="2014-06-16" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 8-year-old Japanese girl (patient 1) with developmental and epileptic encephalopathy-22 (DEE22; 300896) diagnosed clinically as West syndrome, Kodera et al. (2013) identified a de novo heterozygous 2-bp deletion (c.433delTA, NM_005660.1) in the SLC35A2 gene, resulting in a frameshift and premature termination (Tyr145ProfsTer76) within the transmembrane domain. The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, was not found in the Exome Variant Server database or in 408 in-house control exomes. X-chromosome inactivation studies showed a markedly skewed pattern, with expression only of the wildtype allele. Expression of the mutation in mouse neuronal cells showed very low levels of protein expression compared to wildtype, suggesting a loss of function. The patient had onset of tonic seizures at 6 days of age, followed by seizures associated with hypsarrhythmia at 2 months.</Attribute>
              <Citation>
                <ID Source="PubMed">24115232</ID>
              </Citation>
              <XRef DB="OMIM" ID="300896" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC35A2" />
          </GeneList>
          <Name>SLC35A2, 2-BP DEL, 433TA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 433TA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="314375.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 22</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="286893" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 22" MappingRef="Preferred">
        <MedGen CUI="C3806688" Name="SLC35A2-congenital disorder of glycosylation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

